1. Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA Jr: Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (2–2-hydroxyethyl)-amino(ethyl(amino))-9, 10-anthrace- nedione dihydrochloride (NSC 301739), a new anthracenedione. Cancer Research 40:1516- 1518, 1980
2. Von Hoff DD, Coltman CA Jr, Forseth B: Activity of mitoxantrone in a human tumor cloning system. Cancer Research: 41:1853–1855, 1981
3. Dorfman RF, Burke JS, Berard CW: A working formulation of non-Hodgkin's lymphomas: Background, recommendations, histological criteria and relationship to other classifications. In SA Rosenberg and HS Kaplan (eds): Malignant Lymphomas: Etiology, Immunology, Pathology, Treatment. Academic Press, New York 1976, pp 351–368
4. Dimarco A: Adriamycin (NSC-123127) mode and mechanism of action. Cancer Chemother Rep Part 3, 6:91–106, 1975
5. Von Hoff DD, Rozencweig M, Slavik M: Daunomycin: An anthracycline antibiotic effect in acute leukemia. Adv Pharm Chemother 15:1–50, 1978